project id: TCGA-PRAD; case submitter id: TCGA-CH-5788; selected normal wgs: true; state: released; spectrophotometer method: UV Spec; age at index: 69; days to birth: -25233; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1938; age at diagnosis: 25233; ajcc clinical m: M0; ajcc pathologic n: N1; ajcc pathologic t: T3b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 821.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 3; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2007; alcohol history: Not Reported; is ffpe: false; weight: 36.0; intermediate dimension: 0.5; longest dimension: 0.8; preservation method: Unknown; shortest dimension: 0.2; sample id: 144e0265-c04e-4538-a721-94def2570486; sample submitter id: TCGA-CH-5788-01A; portion id: d3e9bf3f-7673-4005-ab01-f3994b970049; portion submitter id: TCGA-CH-5788-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 3.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent tumor cells: 75.0;